Pentacycloundecane derived hydroxy acid peptides: A new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors-Reference-Cited by-同舟云学术

Pentacycloundecane derived hydroxy acid peptides: A new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors

Published:2012-02 Issue: Volume:40 Page:19-29
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Karpoormath Rajshekhar,Sayed Yasien,Govender Patrick,Govender Thavendran,Kruger Hendrik G.,Soliman Mahmoud E.S.,Maguire Glenn E.M.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference85 articles.

1. Report on the Global AIDS Epidemic, in: UNAIDS (2008), Joint United Nations Programme on HIV/AIDS (UNAIDS), (2008), pp. 1–31.

2. Structure and Function of Retroviral Proteases

3. Targeting HIV-1 protease: A test of drug-design methodologies

4. Expedient Method for the Solid-Phase Synthesis of Aspartic Acid Protease Inhibitors Directed toward the Generation of Libraries

5. Protease inhibitor resistance in HIV-infected patients: Molecular and clinical perspectives

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel series of benzo[d]thiazolyl substituted-2-quinolone hybrids: Design, synthesis, biological evaluation and in-silico insights;Journal of Molecular Structure;2021-03

2. An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant;Journal of Computer-Aided Molecular Design;2018-02-03

3. Investigation of the binding free energies of FDA approved drugs against subtype B and C-SA HIV PR: ONIOM approach;Journal of Molecular Graphics and Modelling;2017-09

4. Identification of Binding Mode and Prospective Structural Features of Novel Nef Protein Inhibitors as Potential Anti-HIV Drugs;Cell Biochemistry and Biophysics;2016-12-16

5. Binding Free Energy Calculations of Nine FDA-approved Protease Inhibitors Against HIV-1 Subtype C I36T↑T Containing 100 Amino Acids Per Monomer;Chemical Biology & Drug Design;2016-01-29